Global G-CSF Injection Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 G-CSF Injection Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Long-acting G-CSF Injection
  • 1.2.3 Short-acting G-CSF Injection
• 1.3 Market by Application
  • 1.3.1 Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Neoplastic Diseases
  • 1.3.3 Blood Disorders
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
• 2.2 Global G-CSF Injection Revenue by Region
  • 2.2.1 Global G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global G-CSF Injection Revenue by Region (2018-2023)
  • 2.2.3 Global G-CSF Injection Revenue by Region (2024-2029)
  • 2.2.4 Global G-CSF Injection Revenue Market Share by Region (2018-2029)
• 2.3 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
• 2.4 Global G-CSF Injection Sales by Region
  • 2.4.1 Global G-CSF Injection Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global G-CSF Injection Sales by Region (2018-2023)
  • 2.4.3 Global G-CSF Injection Sales by Region (2024-2029)
  • 2.4.4 Global G-CSF Injection Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global G-CSF Injection Sales by Manufacturers
  • 3.1.1 Global G-CSF Injection Sales by Manufacturers (2018-2023)
  • 3.1.2 Global G-CSF Injection Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of G-CSF Injection in 2022
• 3.2 Global G-CSF Injection Revenue by Manufacturers
  • 3.2.1 Global G-CSF Injection Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global G-CSF Injection Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by G-CSF Injection Revenue in 2022
• 3.3 Global Key Players of G-CSF Injection, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global G-CSF Injection Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of G-CSF Injection, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of G-CSF Injection, Product Offered and Application
• 3.8 Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global G-CSF Injection Sales by Type
  • 4.1.1 Global G-CSF Injection Historical Sales by Type (2018-2023)
  • 4.1.2 Global G-CSF Injection Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global G-CSF Injection Sales Market Share by Type (2018-2029)
• 4.2 Global G-CSF Injection Revenue by Type
  • 4.2.1 Global G-CSF Injection Historical Revenue by Type (2018-2023)
  • 4.2.2 Global G-CSF Injection Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global G-CSF Injection Revenue Market Share by Type (2018-2029)
• 4.3 Global G-CSF Injection Price by Type
  • 4.3.1 Global G-CSF Injection Price by Type (2018-2023)
  • 4.3.2 Global G-CSF Injection Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global G-CSF Injection Sales by Application
  • 5.1.1 Global G-CSF Injection Historical Sales by Application (2018-2023)
  • 5.1.2 Global G-CSF Injection Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global G-CSF Injection Sales Market Share by Application (2018-2029)
• 5.2 Global G-CSF Injection Revenue by Application
  • 5.2.1 Global G-CSF Injection Historical Revenue by Application (2018-2023)
  • 5.2.2 Global G-CSF Injection Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global G-CSF Injection Revenue Market Share by Application (2018-2029)
• 5.3 Global G-CSF Injection Price by Application
  • 5.3.1 Global G-CSF Injection Price by Application (2018-2023)
  • 5.3.2 Global G-CSF Injection Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada G-CSF Injection Market Size by Type
  • 6.1.1 US & Canada G-CSF Injection Sales by Type (2018-2029)
  • 6.1.2 US & Canada G-CSF Injection Revenue by Type (2018-2029)
• 6.2 US & Canada G-CSF Injection Market Size by Application
  • 6.2.1 US & Canada G-CSF Injection Sales by Application (2018-2029)
  • 6.2.2 US & Canada G-CSF Injection Revenue by Application (2018-2029)
• 6.3 US & Canada G-CSF Injection Market Size by Country
  • 6.3.1 US & Canada G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada G-CSF Injection Sales by Country (2018-2029)
  • 6.3.3 US & Canada G-CSF Injection Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe G-CSF Injection Market Size by Type
  • 7.1.1 Europe G-CSF Injection Sales by Type (2018-2029)
  • 7.1.2 Europe G-CSF Injection Revenue by Type (2018-2029)
• 7.2 Europe G-CSF Injection Market Size by Application
  • 7.2.1 Europe G-CSF Injection Sales by Application (2018-2029)
  • 7.2.2 Europe G-CSF Injection Revenue by Application (2018-2029)
• 7.3 Europe G-CSF Injection Market Size by Country
  • 7.3.1 Europe G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe G-CSF Injection Sales by Country (2018-2029)
  • 7.3.3 Europe G-CSF Injection Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China G-CSF Injection Market Size
  • 8.1.1 China G-CSF Injection Sales (2018-2029)
  • 8.1.2 China G-CSF Injection Revenue (2018-2029)
• 8.2 China G-CSF Injection Market Size by Application
  • 8.2.1 China G-CSF Injection Sales by Application (2018-2029)
  • 8.2.2 China G-CSF Injection Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia G-CSF Injection Market Size by Type
  • 9.1.1 Asia G-CSF Injection Sales by Type (2018-2029)
  • 9.1.2 Asia G-CSF Injection Revenue by Type (2018-2029)
• 9.2 Asia G-CSF Injection Market Size by Application
  • 9.2.1 Asia G-CSF Injection Sales by Application (2018-2029)
  • 9.2.2 Asia G-CSF Injection Revenue by Application (2018-2029)
• 9.3 Asia G-CSF Injection Sales by Region
  • 9.3.1 Asia G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia G-CSF Injection Revenue by Region (2018-2029)
  • 9.3.3 Asia G-CSF Injection Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America G-CSF Injection Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America G-CSF Injection Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America G-CSF Injection Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America G-CSF Injection Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country
  • 10.3.1 Middle East, Africa and Latin America G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Amgen Inc.
  • 11.1.1 Amgen Inc. Company Information
  • 11.1.2 Amgen Inc. Overview
  • 11.1.3 Amgen Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Amgen Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Amgen Inc. Recent Developments
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Information
  • 11.2.2 Pfizer Overview
  • 11.2.3 Pfizer G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Pfizer G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Pfizer Recent Developments
• 11.3 Sandoz (Novartis)
  • 11.3.1 Sandoz (Novartis) Company Information
  • 11.3.2 Sandoz (Novartis) Overview
  • 11.3.3 Sandoz (Novartis) G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Sandoz (Novartis) G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sandoz (Novartis) Recent Developments
• 11.4 Spectrum Pharmaceuticals
  • 11.4.1 Spectrum Pharmaceuticals Company Information
  • 11.4.2 Spectrum Pharmaceuticals Overview
  • 11.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 Spectrum Pharmaceuticals G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Spectrum Pharmaceuticals Recent Developments
• 11.5 Biocon Biologics Inc.
  • 11.5.1 Biocon Biologics Inc. Company Information
  • 11.5.2 Biocon Biologics Inc. Overview
  • 11.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Biocon Biologics Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Biocon Biologics Inc. Recent Developments
• 11.6 Coherus BioSciences, Inc.
  • 11.6.1 Coherus BioSciences, Inc. Company Information
  • 11.6.2 Coherus BioSciences, Inc. Overview
  • 11.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 Coherus BioSciences, Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Coherus BioSciences, Inc. Recent Developments
• 11.7 Teva Pharmaceutical
  • 11.7.1 Teva Pharmaceutical Company Information
  • 11.7.2 Teva Pharmaceutical Overview
  • 11.7.3 Teva Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Teva Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Teva Pharmaceutical Recent Developments
• 11.8 Sanofi
  • 11.8.1 Sanofi Company Information
  • 11.8.2 Sanofi Overview
  • 11.8.3 Sanofi G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Sanofi G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Sanofi Recent Developments
• 11.9 Yifan Pharmaceutical
  • 11.9.1 Yifan Pharmaceutical Company Information
  • 11.9.2 Yifan Pharmaceutical Overview
  • 11.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 Yifan Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Yifan Pharmaceutical Recent Developments
• 11.10 CSPC
  • 11.10.1 CSPC Company Information
  • 11.10.2 CSPC Overview
  • 11.10.3 CSPC G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 CSPC G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 CSPC Recent Developments
• 11.11 Jiangsu Hengrui Medicine
  • 11.11.1 Jiangsu Hengrui Medicine Company Information
  • 11.11.2 Jiangsu Hengrui Medicine Overview
  • 11.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.11.4 Jiangsu Hengrui Medicine G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Jiangsu Hengrui Medicine Recent Developments
• 11.12 Qilu Pharmaceutical
  • 11.12.1 Qilu Pharmaceutical Company Information
  • 11.12.2 Qilu Pharmaceutical Overview
  • 11.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.12.4 Qilu Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Qilu Pharmaceutical Recent Developments
• 11.13 Shan Dong Kexing Biopharm
  • 11.13.1 Shan Dong Kexing Biopharm Company Information
  • 11.13.2 Shan Dong Kexing Biopharm Overview
  • 11.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.13.4 Shan Dong Kexing Biopharm G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Shan Dong Kexing Biopharm Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 G-CSF Injection Industry Chain Analysis
• 12.2 G-CSF Injection Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 G-CSF Injection Production Mode & Process
• 12.4 G-CSF Injection Sales and Marketing
  • 12.4.1 G-CSF Injection Sales Channels
  • 12.4.2 G-CSF Injection Distributors
• 12.5 G-CSF Injection Customers

13 Market Dynamics

• 13.1 G-CSF Injection Industry Trends
• 13.2 G-CSF Injection Market Drivers
• 13.3 G-CSF Injection Market Challenges
• 13.4 G-CSF Injection Market Restraints

14 Key Findings in The Global G-CSF Injection Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Long-acting G-CSF Injection
• Table 3. Major Manufacturers of Short-acting G-CSF Injection
• Table 4. Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global G-CSF Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 6. Global G-CSF Injection Revenue by Region (2018-2023) & (US$ Million)
• Table 7. Global G-CSF Injection Revenue by Region (2024-2029) & (US$ Million)
• Table 8. Global G-CSF Injection Revenue Market Share by Region (2018-2023)
• Table 9. Global G-CSF Injection Revenue Market Share by Region (2024-2029)
• Table 10. Global G-CSF Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global G-CSF Injection Sales by Region (2018-2023) & (K Units)
• Table 12. Global G-CSF Injection Sales by Region (2024-2029) & (K Units)
• Table 13. Global G-CSF Injection Sales Market Share by Region (2018-2023)
• Table 14. Global G-CSF Injection Sales Market Share by Region (2024-2029)
• Table 15. Global G-CSF Injection Sales by Manufacturers (2018-2023) & (K Units)
• Table 16. Global G-CSF Injection Sales Share by Manufacturers (2018-2023)
• Table 17. Global G-CSF Injection Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 18. Global G-CSF Injection Revenue Share by Manufacturers (2018-2023)
• Table 19. Global Key Players of G-CSF Injection, Industry Ranking, 2021 VS 2022 VS 2023
• Table 20. G-CSF Injection Price by Manufacturers 2018-2023 (US$/Unit)
• Table 21. Global G-CSF Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global G-CSF Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G-CSF Injection as of 2022)
• Table 23. Global Key Manufacturers of G-CSF Injection, Manufacturing Base Distribution and Headquarters
• Table 24. Global Key Manufacturers of G-CSF Injection, Product Offered and Application
• Table 25. Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global G-CSF Injection Sales by Type (2018-2023) & (K Units)
• Table 28. Global G-CSF Injection Sales by Type (2024-2029) & (K Units)
• Table 29. Global G-CSF Injection Sales Share by Type (2018-2023)
• Table 30. Global G-CSF Injection Sales Share by Type (2024-2029)
• Table 31. Global G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
• Table 32. Global G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
• Table 33. Global G-CSF Injection Revenue Share by Type (2018-2023)
• Table 34. Global G-CSF Injection Revenue Share by Type (2024-2029)
• Table 35. G-CSF Injection Price by Type (2018-2023) & (US$/Unit)
• Table 36. Global G-CSF Injection Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 37. Global G-CSF Injection Sales by Application (2018-2023) & (K Units)
• Table 38. Global G-CSF Injection Sales by Application (2024-2029) & (K Units)
• Table 39. Global G-CSF Injection Sales Share by Application (2018-2023)
• Table 40. Global G-CSF Injection Sales Share by Application (2024-2029)
• Table 41. Global G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
• Table 42. Global G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
• Table 43. Global G-CSF Injection Revenue Share by Application (2018-2023)
• Table 44. Global G-CSF Injection Revenue Share by Application (2024-2029)
• Table 45. G-CSF Injection Price by Application (2018-2023) & (US$/Unit)
• Table 46. Global G-CSF Injection Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 47. US & Canada G-CSF Injection Sales by Type (2018-2023) & (K Units)
• Table 48. US & Canada G-CSF Injection Sales by Type (2024-2029) & (K Units)
• Table 49. US & Canada G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
• Table 50. US & Canada G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
• Table 51. US & Canada G-CSF Injection Sales by Application (2018-2023) & (K Units)
• Table 52. US & Canada G-CSF Injection Sales by Application (2024-2029) & (K Units)
• Table 53. US & Canada G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
• Table 54. US & Canada G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
• Table 55. US & Canada G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 56. US & Canada G-CSF Injection Revenue by Country (2018-2023) & (US$ Million)
• Table 57. US & Canada G-CSF Injection Revenue by Country (2024-2029) & (US$ Million)
• Table 58. US & Canada G-CSF Injection Sales by Country (2018-2023) & (K Units)
• Table 59. US & Canada G-CSF Injection Sales by Country (2024-2029) & (K Units)
• Table 60. Europe G-CSF Injection Sales by Type (2018-2023) & (K Units)
• Table 61. Europe G-CSF Injection Sales by Type (2024-2029) & (K Units)
• Table 62. Europe G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
• Table 63. Europe G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
• Table 64. Europe G-CSF Injection Sales by Application (2018-2023) & (K Units)
• Table 65. Europe G-CSF Injection Sales by Application (2024-2029) & (K Units)
• Table 66. Europe G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
• Table 67. Europe G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
• Table 68. Europe G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 69. Europe G-CSF Injection Revenue by Country (2018-2023) & (US$ Million)
• Table 70. Europe G-CSF Injection Revenue by Country (2024-2029) & (US$ Million)
• Table 71. Europe G-CSF Injection Sales by Country (2018-2023) & (K Units)
• Table 72. Europe G-CSF Injection Sales by Country (2024-2029) & (K Units)
• Table 73. China G-CSF Injection Sales by Type (2018-2023) & (K Units)
• Table 74. China G-CSF Injection Sales by Type (2024-2029) & (K Units)
• Table 75. China G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
• Table 76. China G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
• Table 77. China G-CSF Injection Sales by Application (2018-2023) & (K Units)
• Table 78. China G-CSF Injection Sales by Application (2024-2029) & (K Units)
• Table 79. China G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
• Table 80. China G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
• Table 81. Asia G-CSF Injection Sales by Type (2018-2023) & (K Units)
• Table 82. Asia G-CSF Injection Sales by Type (2024-2029) & (K Units)
• Table 83. Asia G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
• Table 84. Asia G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
• Table 85. Asia G-CSF Injection Sales by Application (2018-2023) & (K Units)
• Table 86. Asia G-CSF Injection Sales by Application (2024-2029) & (K Units)
• Table 87. Asia G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
• Table 88. Asia G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
• Table 89. Asia G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 90. Asia G-CSF Injection Revenue by Region (2018-2023) & (US$ Million)
• Table 91. Asia G-CSF Injection Revenue by Region (2024-2029) & (US$ Million)
• Table 92. Asia G-CSF Injection Sales by Region (2018-2023) & (K Units)
• Table 93. Asia G-CSF Injection Sales by Region (2024-2029) & (K Units)
• Table 94. Middle East, Africa and Latin America G-CSF Injection Sales by Type (2018-2023) & (K Units)
• Table 95. Middle East, Africa and Latin America G-CSF Injection Sales by Type (2024-2029) & (K Units)
• Table 96. Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
• Table 97. Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
• Table 98. Middle East, Africa and Latin America G-CSF Injection Sales by Application (2018-2023) & (K Units)
• Table 99. Middle East, Africa and Latin America G-CSF Injection Sales by Application (2024-2029) & (K Units)
• Table 100. Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
• Table 101. Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
• Table 102. Middle East, Africa and Latin America G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 103. Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2018-2023) & (US$ Million)
• Table 104. Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2024-2029) & (US$ Million)
• Table 105. Middle East, Africa and Latin America G-CSF Injection Sales by Country (2018-2023) & (K Units)
• Table 106. Middle East, Africa and Latin America G-CSF Injection Sales by Country (2024-2029) & (K Units)
• Table 107. Amgen Inc. Company Information
• Table 108. Amgen Inc. Description and Major Businesses
• Table 109. Amgen Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 110. Amgen Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Amgen Inc. Recent Developments
• Table 112. Pfizer Company Information
• Table 113. Pfizer Description and Major Businesses
• Table 114. Pfizer G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 115. Pfizer G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Pfizer Recent Developments
• Table 117. Sandoz (Novartis) Company Information
• Table 118. Sandoz (Novartis) Description and Major Businesses
• Table 119. Sandoz (Novartis) G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 120. Sandoz (Novartis) G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Sandoz (Novartis) Recent Developments
• Table 122. Spectrum Pharmaceuticals Company Information
• Table 123. Spectrum Pharmaceuticals Description and Major Businesses
• Table 124. Spectrum Pharmaceuticals G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 125. Spectrum Pharmaceuticals G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Spectrum Pharmaceuticals Recent Developments
• Table 127. Biocon Biologics Inc. Company Information
• Table 128. Biocon Biologics Inc. Description and Major Businesses
• Table 129. Biocon Biologics Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 130. Biocon Biologics Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Biocon Biologics Inc. Recent Developments
• Table 132. Coherus BioSciences, Inc. Company Information
• Table 133. Coherus BioSciences, Inc. Description and Major Businesses
• Table 134. Coherus BioSciences, Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 135. Coherus BioSciences, Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Coherus BioSciences, Inc. Recent Developments
• Table 137. Teva Pharmaceutical Company Information
• Table 138. Teva Pharmaceutical Description and Major Businesses
• Table 139. Teva Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 140. Teva Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Teva Pharmaceutical Recent Developments
• Table 142. Sanofi Company Information
• Table 143. Sanofi Description and Major Businesses
• Table 144. Sanofi G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 145. Sanofi G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Sanofi Recent Developments
• Table 147. Yifan Pharmaceutical Company Information
• Table 148. Yifan Pharmaceutical Description and Major Businesses
• Table 149. Yifan Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 150. Yifan Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Yifan Pharmaceutical Recent Developments
• Table 152. CSPC Company Information
• Table 153. CSPC Description and Major Businesses
• Table 154. CSPC G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 155. CSPC G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. CSPC Recent Developments
• Table 157. Jiangsu Hengrui Medicine Company Information
• Table 158. Jiangsu Hengrui Medicine Description and Major Businesses
• Table 159. Jiangsu Hengrui Medicine G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 160. Jiangsu Hengrui Medicine G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. Jiangsu Hengrui Medicine Recent Developments
• Table 162. Qilu Pharmaceutical Company Information
• Table 163. Qilu Pharmaceutical Description and Major Businesses
• Table 164. Qilu Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 165. Qilu Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. Qilu Pharmaceutical Recent Developments
• Table 167. Shan Dong Kexing Biopharm Company Information
• Table 168. Shan Dong Kexing Biopharm Description and Major Businesses
• Table 169. Shan Dong Kexing Biopharm G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 170. Shan Dong Kexing Biopharm G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
• Table 171. Shan Dong Kexing Biopharm Recent Developments
• Table 172. Key Raw Materials Lists
• Table 173. Raw Materials Key Suppliers Lists
• Table 174. G-CSF Injection Distributors List
• Table 175. G-CSF Injection Customers List
• Table 176. G-CSF Injection Market Trends
• Table 177. G-CSF Injection Market Drivers
• Table 178. G-CSF Injection Market Challenges
• Table 179. G-CSF Injection Market Restraints
• Table 180. Research Programs/Design for This Report
• Table 181. Key Data Information from Secondary Sources
• Table 182. Key Data Information from Primary Sources

List of Figures

• Figure 1. G-CSF Injection Product Picture
• Figure 2. Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global G-CSF Injection Market Share by Type in 2022 & 2029
• Figure 4. Long-acting G-CSF Injection Product Picture
• Figure 5. Short-acting G-CSF Injection Product Picture
• Figure 6. Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global G-CSF Injection Market Share by Application in 2022 & 2029
• Figure 8. Neoplastic Diseases
• Figure 9. Blood Disorders
• Figure 10. Others
• Figure 11. G-CSF Injection Report Years Considered
• Figure 12. Global G-CSF Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 13. Global G-CSF Injection Revenue 2018-2029 (US$ Million)
• Figure 14. Global G-CSF Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 15. Global G-CSF Injection Revenue Market Share by Region (2018-2029)
• Figure 16. Global G-CSF Injection Sales 2018-2029 ((K Units)
• Figure 17. Global G-CSF Injection Sales Market Share by Region (2018-2029)
• Figure 18. US & Canada G-CSF Injection Sales YoY (2018-2029) & (K Units)
• Figure 19. US & Canada G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
• Figure 20. Europe G-CSF Injection Sales YoY (2018-2029) & (K Units)
• Figure 21. Europe G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
• Figure 22. China G-CSF Injection Sales YoY (2018-2029) & (K Units)
• Figure 23. China G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. Asia (excluding China) G-CSF Injection Sales YoY (2018-2029) & (K Units)
• Figure 25. Asia (excluding China) G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. Middle East, Africa and Latin America G-CSF Injection Sales YoY (2018-2029) & (K Units)
• Figure 27. Middle East, Africa and Latin America G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. The G-CSF Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 29. The Top 5 and 10 Largest Manufacturers of G-CSF Injection in the World: Market Share by G-CSF Injection Revenue in 2022
• Figure 30. Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 31. Global G-CSF Injection Sales Market Share by Type (2018-2029)
• Figure 32. Global G-CSF Injection Revenue Market Share by Type (2018-2029)
• Figure 33. Global G-CSF Injection Sales Market Share by Application (2018-2029)
• Figure 34. Global G-CSF Injection Revenue Market Share by Application (2018-2029)
• Figure 35. US & Canada G-CSF Injection Sales Market Share by Type (2018-2029)
• Figure 36. US & Canada G-CSF Injection Revenue Market Share by Type (2018-2029)
• Figure 37. US & Canada G-CSF Injection Sales Market Share by Application (2018-2029)
• Figure 38. US & Canada G-CSF Injection Revenue Market Share by Application (2018-2029)
• Figure 39. US & Canada G-CSF Injection Revenue Share by Country (2018-2029)
• Figure 40. US & Canada G-CSF Injection Sales Share by Country (2018-2029)
• Figure 41. U.S. G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 42. Canada G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 43. Europe G-CSF Injection Sales Market Share by Type (2018-2029)
• Figure 44. Europe G-CSF Injection Revenue Market Share by Type (2018-2029)
• Figure 45. Europe G-CSF Injection Sales Market Share by Application (2018-2029)
• Figure 46. Europe G-CSF Injection Revenue Market Share by Application (2018-2029)
• Figure 47. Europe G-CSF Injection Revenue Share by Country (2018-2029)
• Figure 48. Europe G-CSF Injection Sales Share by Country (2018-2029)
• Figure 49. Germany G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 50. France G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 51. U.K. G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 52. Italy G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 53. Russia G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 54. China G-CSF Injection Sales Market Share by Type (2018-2029)
• Figure 55. China G-CSF Injection Revenue Market Share by Type (2018-2029)
• Figure 56. China G-CSF Injection Sales Market Share by Application (2018-2029)
• Figure 57. China G-CSF Injection Revenue Market Share by Application (2018-2029)
• Figure 58. Asia G-CSF Injection Sales Market Share by Type (2018-2029)
• Figure 59. Asia G-CSF Injection Revenue Market Share by Type (2018-2029)
• Figure 60. Asia G-CSF Injection Sales Market Share by Application (2018-2029)
• Figure 61. Asia G-CSF Injection Revenue Market Share by Application (2018-2029)
• Figure 62. Asia G-CSF Injection Revenue Share by Region (2018-2029)
• Figure 63. Asia G-CSF Injection Sales Share by Region (2018-2029)
• Figure 64. Japan G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 65. South Korea G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 66. China Taiwan G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 67. Southeast Asia G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 68. India G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 69. Middle East, Africa and Latin America G-CSF Injection Sales Market Share by Type (2018-2029)
• Figure 70. Middle East, Africa and Latin America G-CSF Injection Revenue Market Share by Type (2018-2029)
• Figure 71. Middle East, Africa and Latin America G-CSF Injection Sales Market Share by Application (2018-2029)
• Figure 72. Middle East, Africa and Latin America G-CSF Injection Revenue Market Share by Application (2018-2029)
• Figure 73. Middle East, Africa and Latin America G-CSF Injection Revenue Share by Country (2018-2029)
• Figure 74. Middle East, Africa and Latin America G-CSF Injection Sales Share by Country (2018-2029)
• Figure 75. Brazil G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 76. Mexico G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 77. Turkey G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 78. Israel G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 79. GCC Countries G-CSF Injection Revenue (2018-2029) & (US$ Million)
• Figure 80. G-CSF Injection Value Chain
• Figure 81. G-CSF Injection Production Process
• Figure 82. Channels of Distribution
• Figure 83. Distributors Profiles
• Figure 84. Bottom-up and Top-down Approaches for This Report
• Figure 85. Data Triangulation
• Figure 86. Key Executives Interviewed